Skip to content
Screener

Vericel VCEL Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

Stryker logo
StrykerSYK
$2.66B+1.2%
CONMED logo
CONMEDCNMD
$61.88M-22.5%
Anika Therapeutics logo
Anika TherapeuticsANIK
$730K-3.4%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$638.7M-27.3%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$1.46M+56.2%
MiMedx Group logo
MiMedx GroupMDXG
$10.79M+54.5%

Other financials

Income statement

See full
Revenue$77.5M+22.5%
Gross profit$56.4M+21.0%
Operating income$434.0K+121%
Net income$2.2M+499%
EPS (diluted)$0.04+500%

Balance sheet

See full
Cash & equivalents$125.4M+55.7%
Total debt$93.1M-7.3%
Total equity$370.0M+20.6%
Total assets$502.9M+15.4%

Cash flow

See full
Operating cash flow$16.2M+97.1%
CapEx$1.9M-76.2%
Free cash flow$14.3M+17,504%

Valuation

See full
Market cap$2.25B+25.9%
Enterprise value$2.22B+22.7%
P/E92.9×-159×
P/S7.4×+0.2×

Profitability

See full
Gross margin74.6%+1.1pp
Operating margin6%+5.5pp
Net margin7.9%+5.1pp
FCF margin20.1%

Returns & leverage

See full
Return on equity7.2%+4.6pp
Debt / equity0.3×-0.1×
Current ratio+0.1×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.

The source filing: Vericel’s 10-Q, filed July 30, 2026.

Filed
Jul 30, 2026, 8:49 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-050836
Line itemJune 30, 2026December 31, 2025
Other current liabilities116116
Total current liabilities52,53249,149
Operating lease liabilities78,37982,284
Other long-term liabilities1,9141,896
Total liabilities132,825133,329
COMMITMENTS AND CONTINGENCIES (Note 12)
Shareholders’ equity:
Common stock, no par value; shares authorized — 75,000; shares issued and outstanding — 51,171 and 50,620, respectively750,799730,662

Item 1. Financial Statements (Unaudited)

FAQ

What is Vericel's other non-current liabilities?
Vericel (VCEL) reported other non-current liabilities of $1.91M in Q2 2026.
How has Vericel's other non-current liabilities changed year-over-year?
Vericel's other non-current liabilities increased by 15.6% year-over-year, from $1.66M to $1.91M.
What is the long-term trend for Vericel's other non-current liabilities?
Over 5 years (2020 to 2025), Vericel's other non-current liabilities has grown at a 90.3% compound annual growth rate (CAGR), from $76K to $1.9M.
What does other non-current liabilities mean?
Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.

Ask your AI about Vericel's other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude